Cargando…
Improved outcomes in metastatic germ cell cancer: results from a large cohort study
PURPOSE: Treatment of metastatic germ cell cancer (GCC) is based on the International Germ Cell Cancer Collaborative Group (IGCCCG) prognostic classification published in 1997. 5-year survival rates were reported to be 91%, 79%, and 48% for patients with good, intermediate and poor prognosis, respec...
Autores principales: | Hentrich, Marcus, Debole, Jessica, Jurinovic, Vindi, Gerl, Arthur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817577/ https://www.ncbi.nlm.nih.gov/pubmed/32772232 http://dx.doi.org/10.1007/s00432-020-03343-2 |
Ejemplares similares
-
Large-scale benchmark study of survival prediction methods using multi-omics data
por: Herrmann, Moritz, et al.
Publicado: (2020) -
Subjective quality of life and sexual functioning after germ-cell tumour therapy
por: Fegg, M J, et al.
Publicado: (2003) -
Priority-Lasso: a simple hierarchical approach to the prediction of clinical outcome using multi-omics data
por: Klau, Simon, et al.
Publicado: (2018) -
Development of CNS-type Primitive Neuroectodermal Tumor in Metastatic Testicular Mixed Germ Cell Tumor
por: Odisho, Anobel Y., et al.
Publicado: (2016) -
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
por: Gillessen, Silke, et al.
Publicado: (2021)